-
Vabicaserin (codenamed SCA-136) was a
novel antipsychotic and
anorectic under development by Wyeth. As of 2010 it is no
longer in
clinical trials for...
- pathway.
Vabicaserin (SCA-136) is a 5-HT2C
agonist that has
shown promise in
preliminary testing for the
treatment of schizophrenia.
Vabicaserin has a high...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
- 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)
Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists:
Adatanserin Agomelatine Atypical...
